Latest Breaking News On - Asthika goonewardene - Page 1 : comparemela.com

Compugen Ltd. (NASDAQ:CGEN) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen s First Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.

United-states
American
Yvonne-naughton
Asthika-goonewardene
Alberto-sessa
Daiichi-sankyo
Tony-butler
Michelle-mahler
Rodman-renshaw
David-silberman
Daina-graybosch
Stephen-willey

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2024 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to discuss its First Quarter 2024 Financial Results and Business Updates.

United-kingdom
Erlangen
Bayern
Germany
Munich
Spain
Spanish
Olivia-manser
James-shin
Asthika-goonewardene
Matthew-phipps
John-johnson

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Philadelphia
Pennsylvania
United-states
Australia
Greece
Canada
United-kingdom
American
Greek
Reni-benjamin
Peter-lawson
Jean-marc-bellemin

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript

Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.

United-states
Kansas
Japan
Japanese
Yaron-werber
Anthony-pagano
Tahi-ahmadi
Asthika-goonewardene
James-gordon
Sachin-jain
Judith-klimovsky
Vikram-purohit

Sutro Biopharma (STRO) PT Lowered to $18 at Truist Securities

Sutro Biopharma (STRO) PT Lowered to $18 at Truist Securities
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Asthika-goonewardene
Truist-securities
Sutro-biopharma